Analysts expect Tg Therapeutics, Inc. to report revenue of 250.41 M for Q3 26, against a range of 229.71 M to 271.11 M. The most recent reported quarter, Q2 26, came in at 240.34 M, a 11.0% beat against the 216.44 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 83.88 M | 108.19 M | 120.86 M | 141.15 M | 161.71 M | 192.57 M | 204.92 M | 240.34 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 91.55 M | 115.67 M | 120.10 M | 140.49 M | 168.90 M | 210.61 M | 223.98 M | 235.46 M | 271.11 M | 287.66 M | 315.96 M | 307.02 M | 383.82 M | 454.14 M | 353.29 M | 419.26 M | ||||||||||
| Low Estimate | 77.03 M | 97.05 M | 109.77 M | 118.10 M | 154.80 M | 193.70 M | 191.37 M | 197.42 M | 229.71 M | 236.70 M | 266.47 M | 274.15 M | 348.88 M | 396.17 M | 314.40 M | 358.78 M | ||||||||||
| Consensus Estimate | 84.29 M | 106.36 M | 114.94 M | 129.29 M | 161.85 M | 202.16 M | 207.67 M | 216.44 M | 250.41 M | 262.18 M | 291.22 M | 290.59 M | 366.35 M | 425.15 M | 333.85 M | 389.02 M |
Analysts expect Tg Therapeutics, Inc. to report earnings per share of 0.37 for Q3 26, against a range of 0.35 to 0.39. The most recent reported quarter, Q2 26, came in at 0.05, a 84.4% miss against the 0.32 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.02 | 0.15 | 0.03 | 0.17 | 2.43 | 0.14 | 0.12 | 0.05 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.03 | 0.16 | 0.18 | 0.23 | 0.22 | 0.37 | 0.28 | 0.35 | 0.39 | 0.48 | 0.55 | 0.62 | 1.35 | 0.68 | 0.58 | 0.76 | ||||||||||
| Low Estimate | 0.03 | 0.14 | 0.14 | 0.21 | 0.20 | 0.35 | 0.24 | 0.29 | 0.35 | 0.44 | 0.47 | 0.54 | 1.17 | 0.62 | 0.54 | 0.66 | ||||||||||
| Consensus Estimate | 0.03 | 0.15 | 0.16 | 0.22 | 0.21 | 0.36 | 0.26 | 0.32 | 0.37 | 0.46 | 0.51 | 0.58 | 1.26 | 0.65 | 0.56 | 0.71 |
Pull Wall Street consensus for Tg Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=TGTX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "TGTX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=TGTX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();